Tizanidine Hydrochloride Capsule
Product Images NDC 73352-089

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 73352-089). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trifluent Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label-zfc2 (Label Zfc2)

This text appears to be a fragment from a product label. It mentions the drug Tizanidine Hydrochloride capsules and provides some identification numbers and manufacturing location details. The label includes information such as the batch number, expiration date, and overprinting area. It seems to be a pharmaceutical label for Tizanidine capsules.*

FDA Label Image

Image Description (Zan01 0001 01a)

Not available.*

FDA Label Image

Image Description (Zan01 0001 02a)

FDA Label Image

Image Description (Zan01 0001 03a)

This text mentions the comparison of Ashworth Scores at 8mg and 16mg doses of tizanidine over time post-dose. This data may represent the effects or improvements in muscle tone or spasticity as measured by the Ashworth Scale.*

FDA Label Image

Image Description (Zan01 0001 04a)

This text provides information on the improvement in Ashworth Score with Tizanidine at a mean dose of 26.8 mg compared to a placebo. It mentions different time points including the end of titration, end of maintenance, and endpoint at week 3 and week 7 using the Last Observation Carried Forward method.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.